These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8245481)

  • 21. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
    Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
    Singh AK; Kasinath BS
    Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
    Oleinikov AV; Feliz BJ; Makker SP
    J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of antigens and antibody specificities involved in Heymann nephritis.
    Kamata K; Baird LG; Erikson ME; Collins AB; McCluskey RT
    J Immunol; 1985 Oct; 135(4):2400-8. PubMed ID: 2411795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
    Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA
    J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex.
    Orlando RA; Kerjaschki D; Kurihara H; Biemesderfer D; Farquhar MG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6698-702. PubMed ID: 1495959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of terminal complement complex in active Heymann nephritis.
    de Heer E; Daha MR; Bhakdi S; Bazin H; van Es LA
    Kidney Int; 1985 Feb; 27(2):388-93. PubMed ID: 3886996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.
    Barabas AZ; Cole CD; Barabas AD; Cowan JM; Yoon CS; Waisman DM; Lafreniere R
    Int J Exp Pathol; 2004 Oct; 85(4):201-12. PubMed ID: 15312125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. gp330 and RAP: the Heymann nephritis antigenic complex.
    Farquhar MG; Kerjaschki D; Lundstrom M; Orlando RA
    Ann N Y Acad Sci; 1994 Sep; 737():96-113. PubMed ID: 7944157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive Heymann nephritis in pre- and post-natal rats.
    Challice J; Barabas AZ; Cornish J; Bruce JW; Lannigan R
    Br J Exp Pathol; 1986 Dec; 67(6):915-24. PubMed ID: 3542009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of terminal complement components in experimental immune glomerular injury.
    Adler S; Baker PJ; Pritzl P; Couser WG
    Kidney Int; 1984 Dec; 26(6):830-7. PubMed ID: 6241952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
    Oleinikov AV; Makker SP
    J Pathol; 2000 Oct; 192(2):251-6. PubMed ID: 11004703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different molecular forms of rat kidney gp330, the dominant autoantigen of active Heymann nephritis.
    Jokhadze GG; Oleinikov AV; Kanalas JJ; Makker SP
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):711-3. PubMed ID: 7848267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
    Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
    J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple technique for detecting the antigen of Heymann nephritis in glomeruli by immunofluorescence.
    Makker SP; Makker DM
    Clin Exp Immunol; 1986 Jun; 64(3):615-22. PubMed ID: 3539421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.
    Salant DJ; Darby C; Couser WG
    J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement-independent nephrotoxic serum nephritis in Munich Wistar rats. Immunologic and ultrastructural studies.
    Pilia PA; Boackle RJ; Swain RP; Ainsworth SK
    Lab Invest; 1983 May; 48(5):585-97. PubMed ID: 6341711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerulopathy induced by a single monoclonal autoantibody against GP330.
    Luca ME; Deelder AM; Hogendoorn PC; Daha MR; Galceran M; van Es LA; de Heer E
    Nephrol Dial Transplant; 1995; 10(4):490-6. PubMed ID: 7623990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of sequential glomerular eluates from rats with Heymann nephritis.
    Abrass CK
    J Immunol; 1986 Jul; 137(2):530-5. PubMed ID: 3487574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
    Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
    Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.